What one share of Nkarta holds
We are a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer ("NK") cell therapies. Our company was founded on the belief that engineered NK cell therapies can transform the lives of patients by offering therapies that are clinically meaningful, broadly accessible and unencumbered by the safety concerns often associated with other cell therapy approaches.
Nkarta’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.58 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$1.27 |
| Cash and investments | $0.35 |
| Book value | $3.46 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $0.08 | −$14.41 | $1.32 | −$13.88 | — | −$15.92 |
| 2020 | — | −$5.44 | $0.45 | −$3.04 | — | $9.84 |
| 2021 | — | −$2.62 | $0.15 | −$2.22 | — | $7.61 |
| 2022 | — | −$2.61 | $1.08 | −$2.39 | — | $7.62 |
| 2023 | — | −$2.40 | $0.57 | −$2.33 | $0.00 | $5.56 |
| 2024 | $0.00 | −$1.60 | $0.07 | −$1.53 | $0.00 | $5.78 |
| 2025 | $0.00 | −$1.41 | $0.02 | −$1.22 | $0.00 | $4.39 |
Common questions about Nkarta
How much does one share of Nkarta earn?
Over the last 12 months, Nkarta lost $1.58 for each share.
Does Nkarta pay a dividend?
Nkarta didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Nkarta’s book value per share?
Nkarta’s book value is $3.46 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Nkarta have?
Each share of Nkarta has $0.35 of cash and investments, as of June 30, 2026.
What is Nkarta’s free cash flow per share?
−$1.27 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Nkarta bought back shares?
Nkarta’s share count rose about 4959% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.